Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Yael, Barer"'
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-18 (2023)
Abstract Freezing of gait (FOG) is a debilitating problem that is common among many, but not all, people with Parkinson’s disease (PD). Numerous attempts have been made at treating FOG to reduce its negative impact on fall risk, functional independ
Externí odkaz:
https://doaj.org/article/f3f668f8fd26488c82748b4f8657275c
Autor:
Yael Barer, Rinat Ribalov, Ayelet Yaari, Ron Maor, Qais Arow, John Logan, Gabriel Chodick, Tanya Gurevich
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 9, Iss , Pp 100208- (2023)
Introduction: Data on Huntington’s disease (HD) epidemiology, treatment patterns, and economic burden in Israel are scarce. Methods: Annual prevalence and incidence of HD (ICD-9-CM 333.4) were assessed in the Israel-based Maccabi Healthcare Service
Externí odkaz:
https://doaj.org/article/0f3ade7f2663487b86534879da8cc5f8
Autor:
Barak Mizrahi, Smadar Shilo, Hagai Rossman, Nir Kalkstein, Karni Marcus, Yael Barer, Ayya Keshet, Na’ama Shamir-Stein, Varda Shalev, Anat Ekka Zohar, Gabriel Chodick, Eran Segal
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Although many COVID-19 cases are mild, most information about symptoms is derived from hospitalized patients. Here, the authors link self-reported symptom surveys to primary care data to describe the longitudinal dynamics of COVID-19 in non-hospitali
Externí odkaz:
https://doaj.org/article/4faab26dbf524f87a182461592bebd77
Autor:
Yael Barer, Gabriel Chodick, Raanan Cohen, Meital Grabarnik-John, Xiaolan Ye, Jorge Zamudio, Tanya Gurevich
Publikováno v:
Brain Sciences, Vol 12, Iss 9, p 1126 (2022)
Progressive supranuclear palsy (PSP) is a rare and fatal neurodegenerative movement disorder and no disease modifying therapy (DMT) is currently available. This study aims to assess the epidemiology of PSP in Israel and to describe its clinical featu
Externí odkaz:
https://doaj.org/article/9a1e7a7fe8c145318f4150ea137d5837
Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
ObjectivesTo assess the course of lipid levels over time in postpartum women according to gestational diabetes status, taking into account potential confounders, such as comorbid conditions and body weight.MethodsThe data for the present analysis wer
Externí odkaz:
https://doaj.org/article/8a474830ae0944caa620a7b67014e61d
Autor:
Yael, Barer, Rinat, Ribalov, Ayelet, Yaari, Ron, Maor, Qais, Arow, John, Logan, Gabriel, Chodick, David, Arkadir, Renana, Eitan
Publikováno v:
Journal of Clinical Psychopharmacology. 42:454-460
Tardive dyskinesia (TD) is a hyperkinetic movement disorder caused by exposure to dopamine-receptor blockers. Data on TD burden in Israel are scarce. This analysis assesses the clinical and economic burden of TD in Israeli patients.This retrospective
Autor:
Yael Barer, Raanan Cohen, Meital Grabarnik-John, Xiaolan Ye, Jorge Zamudio, Tanya Gurevich, Gabriel Chodick
Publikováno v:
Journal of Neurology.
Background Progressive supranuclear palsy (PSP) is a rare and fatal neurodegenerative movement disorder with no disease modifying therapy currently available. Data on the costs associated with PSP are scarce. This study aims to assess the direct medi
Autor:
Yael Barer, Tanya Gurevich, Gabriel Chodick, Nir Giladi, Ruth Gross, Raanan Cohen, Lars Bergmann, Yash J. Jalundhwala, Varda Shalev, Meital Grabarnik‐John, Avner Thaler
Publikováno v:
Mov Disord Clin Pract
BACKGROUND: As Parkinson's disease (PD) progresses, response to oral medications decreases and motor complications appear. Timely intervention has been demonstrated as effective in reducing symptoms. However, current instruments for the identificatio
Autor:
Avner Thaler, Yael Barer, Ruth Gross, Raanan Cohen, Lars Bergmann, Yash J. Jalundhwala, Nir Giladi, Gabriel Chodick, Varda Shalev, Tanya Gurevich
Publikováno v:
Advances in Therapy. 39:2009-2024
Patients with advanced Parkinson's disease (PD) may require device-aided therapies (DAT) for adequate symptom control. However, long-term, real-world efficacy and safety data are limited. This study aims to describe real-world, long-term treatment pe